Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and Chemotherapy in Resected Colorectal Peritoneal Carcinomatosis
NCT00766142Phase 2Terminated
- Sponsor
- Institut Bergonié
- Start
- May 2007
- Primary completion
- Sep 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in colorectal cancer (CRC), sponsored by Institut Bergonié. Started May 2007; status: terminated.
02
Drugs
cetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00766142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00766142.